CAR T-Cell Therapy for Leukemia
Sheba Medical Center provides CAR T-cell therapy for leukemia, an advanced form of immunotherapy for both adults and children.
This treatment involves modifying a patient’s own T-cells to recognize and target cancer cells. Sheba offers access to CAR-T therapies, including programs with point-of-care manufacturing capabilities, allowing some treatments to be produced locally.
*Important: Patients accepted into Sheba’s point-of-care CAR-T program benefit from in-house cell manufacturing at Sheba. However, pediatric patients with leukemia are currently only eligible for commercially available CAR-T therapies.
Related Doctors
Arnon Nagler, M.D., M.Sc., served for many years as a direct
Prof. Amos Toren is the former Director of the Pediatric Hem
Dr. Abraham Avigdor is the director of the Institute of Hema
Dr. Michal Yalon specializes in Pediatric-Hemato-Oncology at
Prof. Jacoby, the Head of Sheba’s Pediatric Cell Therapy C
Request a consultation
Sheba Medical Center provides innovative, personalized medical care to patients from around the world. We are the largest, most comprehensive hospital in the Middle East and dedicated to providing advanced and compassionate medicine for everyone.
We welcome all cases, including the rarest and the most challenging. Our medical teams collaborate to provide the best possible health outcomes. From your initial inquiry through the long-term follow-up care, we are here for you.
Request a consultation and a Sheba Case Manager will contact you shortly: